Form 8-K - Current report:
SEC Accession No. 0001144204-16-138423
Filing Date
2016-12-07
Accepted
2016-12-07 17:26:50
Documents
16
Period of Report
2016-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v454581_8k.htm 8-K 25212
2 EX-4.1 v454581_ex4-1.htm EX-4.1 967995
3 EX-4.2 v454581_ex4-2.htm EX-4.2 56131
4 EX-4.3 v454581_ex4-3.htm EX-4.3 51869
5 EX-10.1 v454581_ex10-1.htm EX-10.1 176756
6 EX-10.2 v454581_ex10-2.htm EX-10.2 87152
7 EX-10.3 v454581_ex10-3.htm EX-10.3 159630
8 EX-10.4 v454581_ex10-4.htm EX-10.4 212502
9 GRAPHIC pg11img1_ex4-1.jpg GRAPHIC 2915
10 GRAPHIC pg19img1_ex4-1.jpg GRAPHIC 2511
11 GRAPHIC pg122img1_ex4-1.jpg GRAPHIC 3050
12 GRAPHIC pg122img2_ex4-1.jpg GRAPHIC 4045
13 GRAPHIC pg124img1_ex4-1.jpg GRAPHIC 3963
14 GRAPHIC pg125img1_ex4-1.jpg GRAPHIC 4194
15 GRAPHIC pg127img1_ex4-1.jpg GRAPHIC 3546
16 GRAPHIC pg128img1_ex4-1.jpg GRAPHIC 5317
  Complete submission text file 0001144204-16-138423.txt   1780560
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 162039961
SIC: 2836 Biological Products, (No Diagnostic Substances)